"Probucol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
Below are MeSH descriptors whose meaning is more general than "Probucol".
Below are MeSH descriptors whose meaning is more specific than "Probucol".
This graph shows the total number of publications written about "Probucol" by people in this website by year, and whether "Probucol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Probucol" by people in Profiles.
AGI-1067, a novel antioxidant and anti-inflammatory agent, enhances insulin release and protects mouse islets. Mol Cell Endocrinol. 2010 Jul 29; 323(2):246-55.
Probucol normalizes cholesteryl ester transfer in IDDM. Diabetes Care. 1995 Oct; 18(10):1341-6.
Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism. Horm Metab Res. 1992 Jun; 24(6):289-96.
Nonprogression of coronary artery atherosclerosis in homozygous familial hypercholesterolemia after 31 months of repetitive plasma exchange. Clin Cardiol. 1986 Mar; 9(3):115-9.
Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas. Appl Pathol. 1983; 1(2):89-96.
Repetitive intermittent flow plasma exchange in patients with severe hypercholesterolemia. Atherosclerosis. 1981 Jan-Feb; 38(1-2):149-64.